Literature DB >> 19956488

Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

Gui Young Kwon1, Sang Dae Lee, Eon Sub Park.   

Abstract

PURPOSE: The purpose of this study was to evaluate the clinicopathological significance of the microvessel density and macrophage and mast cell counts in invasive breast carcinomas.
MATERIALS AND METHODS: 45 invasive breast carcinomas were immunohistochemically stained with the endothelial antigen, CD34, and macrophage marker, CD68. 0.1% toluidine blue was used to highlight mast cells. The microvessel and mast cell counts were performed at x200 magnification and the macrophages at x400 magnification.
RESULTS: With the 45 invasive breast carcinomas, there were no statistically significant associations between the mast cell, macrophage and microvessel counts and the tumor size and lymph node status. ER and PR negative mast cells infiltrated more than in cases of positive stati, with statistical significance (p-value=0.010 and 0.005, respectively). The macrophage counts were negatively correlated with the PR status (p-value=0.030). With respect to the c-erbB-2 status, there was no significance correlation with the mast cell, macrophage and microvessel counts. The mast cell counts showed significantly positive correlation with the microvessel counts in the invasive breast carcinomas (p-value=0.015). In a comparison of the macrophage counts with the microvessel counts, a positive tendency for both parameters, but without statistical significance (p-value=0.310).
CONCLUSION: Increasing numbers of mast cells and macrophages were recruited in invasive breast carcinomas, which contribute to angiogenesis. The microvessel density in invasive breast carcinomas had no statistically significant association with the tumor size, lymph node status, and histological grade, presence of DCIS component, estrogen/progesterone receptor status and cerbB-2 status. The evaluation of angiogenesis using these methods is not thought to provide an independent clinicopathological factor in invasive breast carcinomas.

Entities:  

Keywords:  Invasive breast carcinoma; Macrophage; Mast cell; Microvessel density

Year:  2005        PMID: 19956488      PMCID: PMC2785399          DOI: 10.4143/crt.2005.37.2.103

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  24 in total

Review 1.  How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases.

Authors:  P J Polverini
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

Review 2.  Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

Review 3.  Biology and biochemistry of proteinases in tumor invasion.

Authors:  P Mignatti; D B Rifkin
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

4.  Peri and intratumoral macrophage infiltration in laryngeal carcinoma. An immunohistochemical study.

Authors:  B Morra; V Ferrero; M Bussi; D Pacchioni; M Cerrato; G Bussolati
Journal:  Acta Otolaryngol       Date:  1991       Impact factor: 1.494

5.  Heparin and angiogenesis: a low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically.

Authors:  K Norrby
Journal:  Haemostasis       Date:  1993-03

6.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

7.  Comparison of microscopic vascularity in benign and malignant prostate tissue.

Authors:  S A Bigler; R E Deering; M K Brawer
Journal:  Hum Pathol       Date:  1993-02       Impact factor: 3.466

8.  An immunohistochemical study of mononuclear cells in meningiomas.

Authors:  L Bø; S J Mørk; H Nyland
Journal:  Neuropathol Appl Neurobiol       Date:  1992-12       Impact factor: 8.090

Review 9.  Macrophages: modulators of breast cancer progression.

Authors:  Elaine Y Lin; Jeffrey W Pollard
Journal:  Novartis Found Symp       Date:  2004

10.  Urokinase and macrophages in tumour angiogenesis.

Authors:  R Hildenbrand; I Dilger; A Hörlin; H J Stutte
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  1 in total

1.  Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.

Authors:  Wenrui Hao; Avner Friedman
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.